Youris.com

youris.com is an independent non-profit media agency promoting the leading-edge European innovation via TV media and the web. youris.com designs and implements media communication strategies for large research organisations and EU-funded projects and is able to establish permanent links between the research communities and the media. To date, more than 120 EU-funded projects and independent research organisations successfully exploited the youris.com platform to implement their communication strategy towards the media and the general public.

Address
youris.com G.E.I.E. dreve du Pressoir 38 B-1190 Brussels, Belgium
Website
http://www.youris.com

Subscribe to rss feed

Medical research

Two new technologies that could change cancer treatment

By studying the biomechanics of cancer in the breast and bladder, the Mechano-Control and Edit projects are developing new ways of cancer identification and treatment that could open up new avenues in cancer research

Neuroscience

Can nanotechnology rewire an injured spinal cord?

According to the World Health Organisation, up to a half-million people around the world suffer a spinal cord injury each year. Often caused by road traffic crashes, accidents or violence, the loss of motor control or paralysis ...

Neuroscience

The art of non-deterministic behaviour

From the dreams of a mouse to real snail email, "boredomresearch" extract the poetic dynamics of natural complex systems.

Immunology

The increasing rates of food allergy and food intolerance

In recent years, researchers have noted a significant increase in food intolerances and allergy. But when is it really an allergy? Is it possible to prevent by intervening in the first few months of life?

Medical research

New treatment against transplantation complications tested

It is not uncommon for kidney transplants to fail. Once transplanted, the kidney must connect back with the blood supply to start working properly and be truly accepted by the body. Delays can cause complications. An example, ...

Medications

Fast-tracking rare disease drug candidates' approval

Aspiring new drugs face long and stringent tests on safety and effectiveness before making it to market. And rightly so. But giving drugs special designations that bring with them the right incentives can help bring them ...

Immunology

Network of experts join forces to fight myasthenia gravis

Collaboration between research groups is key in tackling rare diseases such as auto-immune disease myasthenia gravis (MG). Indeed, the rarity of the disease means that it can be difficult to collect enough samples of blood ...

page 1 from 8